Verition Fund Management
BMY icon

Verition Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Verition Fund Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,989
Closed -$2.33M – 2395
2025
Q4 		$2.16M Sell
39,989
-311,549
-89% -$15M 0.01% 1539
2025
Q3 		$15.9M Buy
351,538
+175,113
+99% +$8.18M 0.07% 283
2025
Q2 		$8.17M Buy
176,425
+116,510
+194% +$5.72M 0.04% 653
2025
Q1 		$3.65M Sell
59,915
-24,410
-29% -$1.42M 0.02% 1089
2024
Q4 		$4.77M Sell
84,325
-72,955
-46% -$4.08M 0.02% 917
2024
Q3 		$8.14M Buy
157,280
+39,597
+34% +$1.86M 0.04% 521
2024
Q2 		$4.89M Buy
117,683
+52,357
+80% +$2.34M 0.03% 743
2024
Q1 		$3.54M Sell
65,326
-28,312
-30% -$1.44M 0.02% 892
2023
Q4 		$4.8M Buy
93,638
+42,457
+83% +$2.23M 0.04% 459
2023
Q3 		$2.97M Buy
51,181
+26,534
+108% +$1.63M 0.03% 635
2023
Q2 		$1.58M Buy
+24,647
New +$1.65M 0.02% 781
2023
Q1 		– Sell
-48,010
Closed -$3.45M – 2167
2022
Q4 		$3.45M Buy
48,010
+24,846
+107% +$1.87M 0.05% 439
2022
Q3 		$1.65M Buy
23,164
+4,634
+25% +$336K 0.02% 1047
2022
Q2 		$1.43M Buy
18,530
+12,722
+219% +$969K 0.03% 842
2022
Q1 		$424K Sell
5,808
-14,555
-71% -$977K 0.01% 1986
2021
Q4 		$1.27M Buy
20,363
+6,172
+43% +$362K 0.01% 1144
2021
Q3 		$840K Buy
14,191
+2,781
+24% +$183K 0.01% 1006
2021
Q2 		$762K Sell
11,410
-38,911
-77% -$2.54M 0.01% 915
2021
Q1 		$3.18M Buy
50,321
+44,154
+716% +$2.75M 0.04% 296
2020
Q4 		$383K Buy
6,167
+393
+7% +$24.2K ﹤0.01% 744
2020
Q3 		$348K Sell
5,774
-283
-5% -$17K 0.01% 722
2020
Q2 		$356K Sell
6,057
-1,648
-21% -$98.6K 0.01% 732
2020
Q1 		$429K Sell
7,705
-105,495
-93% -$6.45M 0.02% 357
2019
Q4 		$7.27M Buy
+113,200
New +$6.48M 0.13% 119
2019
Q2 		– Sell
-17,636
Closed -$821K – 1077
2019
Q1 		$841K Buy
17,636
+12,499
+243% +$623K 0.03% 456
2018
Q4 		$267K Sell
5,137
-24,834
-83% -$1.33M 0.02% 659
2018
Q3 		$1.86M Sell
29,971
-1,957
-6% -$116K 0.07% 327
2018
Q2 		$1.77M Buy
31,928
+19,557
+158% +$1.06M 0.11% 233
2018
Q1 		$782K Sell
12,371
-5,116
-29% -$329K 0.06% 465
2017
Q4 		$1.07M Buy
+17,487
New +$1.09M 0.1% 229
2017
Q3 		– Sell
-8,190
Closed -$456K – 1158
2017
Q2 		$456K Buy
8,190
+80
+1% +$4.35K 0.04% 469
2017
Q1 		$441K Sell
8,110
-9,532
-54% -$523K 0.04% 635
2016
Q4 		$1.03M Sell
17,642
-2,024
-10% -$111K 0.09% 262
2016
Q3 		$1.06M Buy
+19,666
New +$1.26M 0.11% 203
2014
Q4 		– Sell
-6,230
Closed -$319K – 381
2014
Q3 		$319K Buy
6,230
+1,808
+41% +$90.3K 0.05% 371
2014
Q2 		$215K Buy
+4,422
New +$218K 0.02% 527
2013
Q4 		– Sell
-6,647
Closed -$308K – 511
2013
Q3 		$308K Buy
+6,647
New +$292K 0.05% 321

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management's BMY Position: Q1 2026 in Review

Verition Fund Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 39,989 shares — an estimated $2.33M sold.

Verition Fund Management first reported a position in BMY in Q3 2013 and held it in 37 quarters. The position peaked at $15.9M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Verition Fund Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 39,989 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.33M.
  • Verition Fund Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 37 quarters.
  • Verition Fund Management's Bristol-Myers Squibb position peaked at $15.9M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.